Balyasny Asset Management LLC Exact Sciences Corp Put Options Transaction History

Balyasny Asset Management LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $2.32 Million - $3.87 Million	54,700 New	54,700 $3.72 Million
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $3.97 Million - $5.2 Million	70,500 New	70,500 $4.87 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $2.07 Million - $3.2 Million	-64,900 Reduced 18.98%	277,000 $9 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $6.3 Million - $13.5 Million	176,800 Added 107.09%	341,900 $13.5 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $3.3 Million - $4.73 Million	57,300 Added 53.15%	165,100 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $6.47 Million - $8.99 Million	89,300 Added 482.7%	107,800 $8.39 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $1.67 Million - $2.29 Million	18,500 New	18,500 $1.77 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $3.88 Million - $4.99 Million	-50,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $2.26 Million - $3.06 Million	25,000 Added 100.0%	50,000 $4.52 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $12.3 Million - $16.2 Million	-137,000 Reduced 84.57%	25,000 $2.89 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $6.94 Million - $10.8 Million	112,000 Added 224.0%	162,000 $14 Million
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $2.32 Million - $3.03 Million	50,000	50,000 $2.63 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.